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Background/aim: Lipopolysaccharide (LPS)-induced endotoxemia can cause serious organ damage such as acute lung injury and death
by triggering the secretion of proinflammatory cytokines and acute-phase reactants. The goal of this study was to evaluate the effects of
β-glucan on inflammatory mediator levels and histopathological changes in LPS-induced endotoxemia.
Materials and methods: Forty-seven male Wistar albino rats were randomly allocated into four groups as follows: control group, LPS
group (10 mg/kg LPS), LPS + β-glucan group (100 mg/kg β-glucan before LPS administration), and β-glucan group. Twelve hours after
LPS administration, lung and serum samples were collected. Concentrations of IL-6, IL-8, C-reactive protein (CRP), and procalcitonin
were measured in the serum at hours 0 (basal) and 12. The severity of lung damage was assessed by an appropriate histopathological
scoring system.
Results: Serum levels of CRP in the LPS group at 12 h were significantly higher than in the other groups, whereas serum IL-6 levels in
the LPS and LPS + β-glucan groups at 12 h were significantly decreased. The mean histopathological damage score of the LPS group was
slightly higher than that of the LPS + β-glucan group. Moreover, mortality rate was significantly decreased in the LPS + β-glucan group
versus the LPS group.
Conclusion: β-Glucan reduces endotoxemia-induced mortality and might be protective against endotoxemia-induced lung damage.
Key words: Endotoxin, acute lung injury, β-glucan, C-reactive protein, interleukin-6

1. Introduction
Lipopolysaccharide (LPS), an important cell-wall
component of gram-negative bacteria and a potent
inducer of the host immune system, causes endotoxemia
(1). LPS administration induces systemic inflammation
characterized by increases in proinflammatory cytokines
without bacteremia (2). Several markers and acutephase reactants have been suggested to provide clues
about the severity of endotoxemia. Proinflammatory
cytokines such as IL-6 and IL-8, which play critical role
in all phases of host defense, are secreted mainly by
macrophages (3). Cytokines induce production of acutephase proteins including C-reactive protein (CRP) and
procalcitonin. CRP is a specific late infection marker,
whereas cytokines and procalcitonin are early infection
markers. Therefore, the use of multiple markers such
as CRP, procalcitonin, IL-6, and IL-8 is useful for
monitoring the severity of endotoxemia (4). In several
* Correspondence: meriraz@mynet.com

studies, a positive correlation was shown between these
mediators and endotoxemia (5,6).
β-Glucans are glucose polymers of the cell walls of
yeast, fungi, and cereal plants. They are accepted to be
among the most powerful immune response modifiers.
Since the beneficial effects of β-glucans on the immune
system are devoid of toxic and adverse effects, studies have
focused on β-glucan molecules. Several studies reported
that β-glucans inhibit tumor development, promote wound
healing, protect from ototoxicity, restore hematopoiesis,
induce production of cytokines, increase salivary IgA
secretion, prolong survival, and enhance defense against
bacterial, viral, fungal, and parasitic challenges (7–9).
In the present study, we aimed to investigate the
effects of β-glucan on LPS-induced lung injury by
histopathological and biochemical analysis. The alterations
in plasma concentrations of proinflammatory mediators
were determined by measurements at hours 0 (basal) and
12 following LPS administration.
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2.4. Measurement of serum inflammatory factor levels
Blood samples were obtained from all groups at hours
0 and 12 after administration of LPS. The sera were
immediately separated by centrifuging at 4000 rpm for 10
min and were stored at –70 °C until analysis. IL-6 and IL-8
levels were measured with enzyme-linked immunosorbent
assay (ELISA) kits (Rat IL-6 and IL-8 Platinum ELISA,
eBioscience, Bender MedSystems GmbH, Vienna, Austria).
The levels of procalcitonin in plasma were quantified using
ELISA kits (Rat PCT Elisa Kit, Eastbio Pharm, Hangzhou
Eastbiopharm Co., Hangzhou, China). The levels of CRP
in plasma were quantified using ELISA kits (Rat CRP Elisa
Kit, Assaypro, St. Charles, MO, USA) according to the
manufacturer’s instructions.
2.5. Statistical analysis
Statistical analyses were carried out using SPSS 19.0.
All data are presented as mean ± standard deviation.
Distribution of the groups was analyzed with one-sample
Kolmogorov–Smirnov test. The differences among the
cytokine measurements of the groups were carried out
by one-way analysis of variance (ANOVA) followed by
Tukey’s multiple comparisons test. Histopathological
damage scores were analyzed by Mann–Whitney U-test.
Basal and 12-h cytokine measurements in each group
were analyzed by two-way ANOVA with Dunn’s multiple
comparison tests. Mortality rates were analyzed by chisquare test. P < 0.05 was considered significant.
3. Results
3.1. Survival
At 12 h after LPS injection, 9 of 18 rats (50%) in the LPS
group and 2 of 13 rats (15.4%) in the LPS + β-glucan
group had died. β-Glucan administration before LPS
significantly reduced the mortality rate (P < 0.05). All rats
from the control and β-glucan groups survived until the
end of the experimental protocol (Figure 1).
3.2. Inflammatory parameters
Serum concentrations of IL-6, IL-8, procalcitonin, and
CRP obtained from animals in each group at hours 0 and
12 were determined. Levels of IL-8, procalcitonin, and
60
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2. Materials and methods
2.1. Animals and groups
All experimental protocols were approved by the
Experimental Animals Ethics Board of Bezmialem Vakıf
University. The care and handling of the animals was
done in accordance with National Institutes of Health
guidelines. Animals were obtained from the Bezmialem
Vakıf University Research Center. The rats were kept at a
constant temperature (22 ± 1 °C) with 12-h light and 12-h
dark cycles and were provided standard rat chow and tap
water ad libitum.
Forty-seven male Wistar albino rats, weighing 315 to
350 g, were included in this study. Rats were randomly
divided into four experimental groups as follows: control
group (n = 7), LPS group (n = 18), LPS + β-glucan group
(n = 15), and β-glucan group (n = 7).
2.2. Experimental protocols
All rats were anesthetized with 80 mg/kg ketamine (Ketalar,
Pfizer, Turkey) and 5 mg/kg xylazine HCl (Rompun, Bayer,
Turkey). Following anesthesia, a p50 polyethylene cannula
was inserted into the common carotid artery for the
administration of LPS and for taking blood samples before
β-glucan and saline pretreatment for basal measuring of
inflammatory parameters. β-Glucan groups received 100
mg kg–1 day–1 β-glucan (Sigma, St. Louis, MO, USA) via
intragastric gavage for 3 days before LPS administration.
The control group received an equal volume of saline. In
order to induce acute lung injury, 10 mg/kg LPS (derived
from Escherichia coli endotoxin; serotype O111:B4, Sigma)
dissolved in sterile saline was administered to the rats in
LPS groups via a p50 polyethylene cannula over a period
of 10 min. Twelve hours after LPS administration, blood
and lung tissue samples were collected. An euthanasia
procedure was then performed.
2.3. Histopathological examination
Tissue samples were placed in 10% neutral formalin and
prepared for routine paraffin embedding. Sections of
tissues were cut at 5 µm thick, mounted on slides, and
stained with hematoxylin-eosin (H&E) and Masson’s
trichrome methods. Samples were examined and scored
by a blind observer using a Nikon Eclipse i5, a light
microscope with a Nikon DS-Fi1c camera, and the Nikon
NIS Elements version 4.0 image analysis system (Nikon
Instruments Inc., Tokyo, Japan).
The main histopathological lung damage score was
calculated as previously described (10), with a minor
modification. In brief, histopathological lung damage
was assessed by scoring alveolar congestion, hemorrhage,
infiltration or aggregation of leukocytes in air spaces/vessel
walls, perivascular/interstitial edema, and thickness of the
alveolar wall/hyaline membrane formation. The severity
for each item was rated on a 4-point scale graded from 0
(minimal) to 3 (maximal), giving a range of total scores
from 0 to 15 (most severe).
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Figure 1. Mortality rates after LPS administration. *P < 0.05 vs.
the LPS group.
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CRP in all groups increased at hour 12 compared to the
basal level. These increases may have resulted from the
invasive applications, including the insertion of a cannula,
applied to all animals. Therefore, these elevations were
not marked in the figures. At hour 12, no differences were
detected among serum IL-8 and procalcitonin levels of any
groups (Figures 2 and 3).
CRP levels in the LPS group were significantly increased
compared with the control and β-glucan groups at hour
12 after LPS injection (P < 0.05). LPS-induced increase in
CRP level was significantly reduced with the application of
β-glucan before LPS (P < 0.05; Figure 3).
At hour 12, IL-6 levels of the LPS and LPS + β-glucan
groups were significantly lower than those of the control
and β-glucan groups (P < 0.05). However, there was no
significant difference between IL-6 levels of the LPS and
LPS + β-glucan groups. Furthermore, IL-6 levels of the LPS
and LPS + β-glucan groups at hour 12 were significantly
lower than the basal levels Additionally, IL-6 level at hour
12 in the control group was increased. However, this
elevation was attenuated by using only β-glucan (Figure 2).

3.3. Histopathological findings
Samples from the control and β-glucan groups revealed
normal lung histology (Figures 4A and 4B, respectively).
However, advanced inflammation of the alveolar wall,
leukocyte (mainly neutrophil and lymphocyte) infiltration
and aggregation of leukocytes in air spaces or vessel wall,
congestion, perivascular and interstitial edema, prominent
thickness of alveolar wall, and alveolar collapse were
observed in the LPS group (Figures 4C and 4D). In the
LPS + β-glucan group, the findings indicating lung injuries
were somewhat improved (Figures 4E and 4F). The main
histopathological lung damage scores were 1.0 ± 1.07 in
the control group, 9.7 ± 1.8 in the LPS group, 6.3 ± 1.93 in
the LPS + β-glucan group, and 0.7 ± 0.76 in the β-glucan
group. LPS administration significantly increased lung
injury score in the LPS and LPS + β-glucan groups versus
the control and β-glucan groups (P < 0.05). β-Glucan
pretreatment attenuated the LPS-induced increase in the
lung injury score (Figure 5). In accordance with the lung
injury scores, cell infiltration rates were 0.38 ± 0.52 in the
control group, 2.67 ± 0.5 in the LPS group, 2.22 ± 0.83 in
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Figure 2. Serum IL-6 and IL-8 levels at hour 0 (basal) and hour
12 for all groups. IL-8 levels were significantly elevated in all
groups at hour 12 versus basal levels in each group (not labeled).
IL-6 was significantly elevated in the control group at hour 12
versus the basal level (not labeled). * P < 0.05 vs. basal level of the
same groups and 12-h levels of the other groups; ** P < 0.05 vs.
12-h levels of the other groups.
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Figure 3. Serum CRP and procalcitonin levels of all groups. CRP
and procalcitonin levels were significantly elevated in all groups
at hour 12 versus basal levels in each group (not labeled). *P <
0.05 vs. the other groups.
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Figure 4. Histopathological features of the lung tissue samples in all groups. (A) Section from
control group reveals normal lung histology, H&E, 20×. (B–D) Sections obtained from LPS
group: (B) interstitial edema, congestion, inflammatory cell infiltration, alveolar collapse, and
thickening of alveolar wall are observed, H&E, 20×; (C) infiltration and aggregation of leukocytes
in air spaces or vessel wall are prominent, H&E, 40×; (D) congestion and obvious perivascular
edema are observed, H&E, 20×. (E, F) Sections obtained from the LPS + β-glucan group: (E)
congestion, inflammatory cell infiltration, alveolar collapse, and thickening of alveolar wall are
observed to the left, whereas the right side seems normal, H&E, 10×; (F) mild congestion and
perivascular edema are observed, and numerous leukocytes are seen within the lumen of the
vessels, H&E, 20×.

the LPS + β-glucan group, and 0.29 ± 0.49 in the β-glucan
group. LPS administration significantly elevated cell
infiltration in the LPS and LPS + β-glucan groups versus
the control and β-glucan groups (P < 0.05). However, no
significant difference was detected between the LPS and
LPS + β-glucan groups (Figure 5).
4. Discussion
Endotoxins can cause serious organ damage and death
by triggering activation of inflammatory cells (11) and a
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sequence of events including blood vessel dilation, increased
blood flow, and leukocyte infiltration (12). Massive
accumulation of neutrophils, interstitial pulmonary
edema, and increased expression of proinflammatory
mediators are the major characteristics of acute pulmonary
injury (13). Neutrophil adhesion plays an important role
in the development of chronic pulmonary inflammation
(14,15). In LPS-induced endotoxemia, enhanced immune
response is accomplished by an increased production of
the proinflammatory cytokines.
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Figure 5. Lung injury and leukocyte infiltration scores of all
groups. *P < 0.05 vs. the control and β-glucan groups.

β-Glucans, accepted to have no toxic or adverse effects,
are known be beneficial for immune system functions (3).
β-Glucans are potent immunostimulants of both natural
and adaptive immunity. Several experimental studies
have reported antibacterial, antifungal, antiviral, and
antioxidant activities of β-glucans (14,16–19). Babayigit
et al. (20) reported that β-glucan is effective in decreasing
leukocyte infiltration in lung damage and improving
survival. β-Glucan has also been reported to decrease
mortality rates in experimental sepsis models (21–23).
Das et al. (24) demonstrated that β-glucan suspension
increases the immunity of A. testudineus spawns against
S. parasitica and reduce mortality. In the present study,
the effect of β-glucan on lung injury was assessed by
biochemical and histopathological analysis. β-Glucan
derived from barley diminished the LPS-induced mortality
rate in rats. Additionally, histopathological evaluation
showed that LPS caused prominent inflammation in the
alveolar wall, leukocyte (mainly neutrophil) infiltration
and aggregation of leukocytes in air spaces or vessel
wall, and pulmonary congestion. β-Glucan slightly
reduced these findings. In accordance with our study,
several other studies reported that β-glucan attenuated
histopathological changes associated with lung injury in
experimental rat models (8,19,23). The protective effect of
β-glucan against endotoxemia may be due to a reduction
in proinflammatory cytokines. On the other hand,
neutrophils assume an important role in the defense system.
In fact, neutrophils cause tissue damage by carrying potent
compounds including toxic oxygen radicals and granular
proteins. Suppression of neutrophils by β-glucan may play

a protective role against experimental lung injury.
IL-6 is an important cytokine of the early host response
against the infection. Its concentration increases sharply
after exposure to bacterial products and precedes the
increase in CRP (20,24). However, in our study, serum
levels of IL-6 after LPS injection were significantly
decreased compared with the basal levels in the LPS and
LPS + β-glucan groups. Serum levels of IL-6 were also
significantly decreased in the β-glucan group versus the
control group, but no significant difference was detected
in level of IL-6 between the basal measurement and at 12 h
in the β-glucan group. Similarly, Bedirli et al. (23) reported
that administration of β-glucan completely inhibited the
elevation of IL-6. Therefore, we suggest that β-glucan may
reduce the level of IL-6. The diminished level of IL-6 after
LPS administration may be due to its very short half-life
(5,6) and also the presence of excessive antiinflammatory
response. In the late phase of sepsis, the amount of
produced proinflammatory cytokines of monocytes
and lymphocytes may be severely impaired due to lower
expression of MHC class II and decreased lymphocyte
proliferation and activation (25–27). The impairment of
production of proinflammatory cytokines is known as
‘immunoparalysis’. We could only measure serum values
of IL-6 at hours 0 and 12. Nevertheless, we realized that
β-glucan had no significant effect on IL-6 levels of LPSadministrated groups at hour 12.
During inflammation, IL-6 concentration increases
and returns to normal values more quickly than that of CRP
(28). CRP, an acute-phase reactant, is synthesized by the
liver in the early phase of infection and tissue injury. IL-6
is the major inducer of CRP production. It is synthesized
within 6 to 8 h of exposure to an infective agent or tissue
damage, peaks at about 24 to 48 h, and then diminishes over
time as the inflammation resolves (5,29). In the present
study, serum levels of IL-6 and CRP were assessed after the
injection of LPS. CRP levels were increased at 12 h after
LPS injection as compared to the basal levels. Samuelsen
et al. (30) reported that increased intake of barley
β-glucan decreased levels of CRP and proinflammatory
cytokines. Similarly, we found a significant decrease in
the level of CRP following β-glucan treatment. However,
some studies reported that consumption of β-glucan did
not affect plasma level of CRP in hypercholesterolemic
subjects (31,32). Pionnier et al. (33) showed that oral
administration of β-glucan for 14 days stimulated serum
CRP levels during an Aeromonas salmonicida infection in
an animal study. Since a few studies confirmed the effect
of β-glucan on serum CRP levels, we suggest that further
studies need to be performed.
Procalcitonin, another acute-phase marker, is
synthesized by the liver and induced by similar means
as CRP. Although its level is undetectable in the blood of
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healthy people, its concentration increases in relation to
the intensity of inflammatory reaction due to infection
in septic patients. Serum concentrations of procalcitonin
begin to rise 4 h after exposure to the bacterial endotoxin,
peak at 6–8 h, and remain elevated for at least 24 h in
humans. It has been shown that a great amount of
procalcitonin is produced by human liver cells following
IL-6 stimulation. The procalcitonin level remains
continuously high despite a decrease in IL-6 levels in
parallel with the severity of the ongoing infection (5).
Elevations in procalcitonin are generally observed
before CRP rises and they decline in a much shorter
time. Additionally, when patients respond to therapy,
procalcitonin levels return to normal much more quickly
than those of CRP (29). Accordingly, we found that at
hour 12 CRP was increased after LPS administration, and
pretreatment with β-glucan returned its level to the level
of the control group. However, we did not observe any
change in procalcitonin levels among groups at 12 hours.
We suggest that it may have increased to its peak levels
and returned to normal during the first 12-h period.
In the present study, systemic administration of LPS
caused no significant change in plasma levels of IL-8
among groups at hour 12. Theuwissen et al. (31) reported
that consumption of β-glucan in hypercholesterolemic

subjects did not change plasma concentrations of
inflammatory parameters, including IL-6, IL-8, and CRP.
Similarly, Samuelsen et al. (30) reported that a mixedlinked β-glucan isolated from barley showed no significant
effect on IL-8 secretion. In contrast to these studies,
human whole blood incubated with soluble yeast β-glucan
showed enhanced production of IL-6 and IL-8. Moreover,
when LPS was added together with this β-glucan, IL-8
concentration was strongly increased, whereas no further
increase in IL-6 concentration was observed (25).
In conclusion, β-glucan treatment decreased mortality
rate. Moreover, it decreased lung damage according
to histopathological data in the present experimental
endotoxemia study. Decreases in leukocyte infiltration
and CRP levels by β-glucan may be useful in prevention of
acute lung injury. We suggest that β-glucan may support
conventional therapy. However, further studies are
required to evaluate the potential of β-glucan as an option
for protecting lungs from LPS-induced endotoxemia.
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